Hours Today : 8:00am - 6:00pm

Brand

Acuvue Canada

Today, ACUVUE® Brand Soft Disposable Contact Lenses remain the number one brand in the world. The ACUVUE® Brand is worn by more people globally than any other contact lens brand. The ACUVUE® Brand is truly transforming the world's vision by providing an outstanding range of contact lens options to meet the vision needs and wants of just about everyone requiring vision correction.

About this brand

Related Promotions

Acuvue Oasys


 
Why ask for them?
ACUVUE® OASYS® Brand features next generation HYDRACLEAR® Plus** technology that can keep your eyes comfortable all day long - even in tough surroundings that can make your eyes feel tired and dry.
Super Comfortable
Patented HYDRACLEAR® Plus technology makes contacts ultra-smooth and more wettable, with a higher transmission of oxygen than conventional lenses. That means more comfort and less dryness, even in tough environments that might dry out other lenses, such as long hours in front of a computer, on an airplane, or in an air conditioned or heated room or car.
UV Protection
UV radiation can be harmful to your eyes. That's why ACUVUE® OASYS® Brand with HYDRACLEAR® Plus lenses help protect the covered portions of your eyes by blocking at least 96% of the UV-A radiation and 99% of the UV-B radiation from the sun.


Bedford Eye Care - Finalist for 2017 Business of the Year in the Halifax Business Awards

Bedford Eye Care is a Finalist for Business of the Year!

We are so very grateful to our patients, the community and the outstanding service team in the practice for the support you all continue to show to us in our many years in business.

We're honoured to be selected by the Halifax Chamber of Commerce among a diverse group of outstanding and well-known finalists for this prestigious award. We believe it's a reflection of the commitment we have to delivering the highest quality care to our patients and for pushing into new areas of innovative care, including our new dry eye and traumatic brain injury clinics, as well as our commitment to patient and public education in these critical new areas of research and treatment.